SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alembic Ltd (ALEMBICLTD)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506235 NSE: ALEMBICLTD Construction - Real Estate | Small Cap | Alembic Share Price

₹87.15 1.17 (1.36%)

As on 05-Jun'26 09:51

Alembic Ltd (ALEMBICLTD)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506235 NSE: ALEMBICLTD Construction - Real Estate | Small Cap | Alembic Share Price

₹87.15 1.17 (1.36%)

As on 05-Jun'26 09:51

Key Metrics
Valuation Multiples
Market Cap
₹2,208 Cr.
Current Price
₹87.2
52-Week Low / High
₹71 / 126
TTM EPS
₹12.4
TTM Sales
₹240 Cr.
Book Value per Share
₹89.6
P/E Ratio
6.96
Lower than its 5-year historical median
Industry PE
42.8
Price to Book (P/B)
0.96
Lower than its 5-year historical median
Price to Sales (P/S)
9.20
Lower than its 5-year historical median
EV/EBITDA
13.55
Lower than its 5-year historical median
Dividend Yield
2.44%
Profitability Efficiency
Return on Equity (ROE)
6.39%
Outperforms industry median
Return on Capital Employed (ROCE)
6.95%
Outperforms industry median
Return on Assets (ROA)
5.96%
Operating Profit Margin
42.2%
Net Profit Margin
65.16%
Gross Profit Margin
74.9%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
40.89%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
64.81%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
55.67%
Asset Quality
Promoter Holding
70.88%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹2,249 Cr.
Equity
₹51.4 Cr.
Face Value
₹2
All Time Low / High
₹0.68 / 169.00

Alembic stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Alembic Ltd a good quality company?
Alembic Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Alembic Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Alembic Ltd vs industry peers?
Alembic Ltd revenue CAGR is 24.58%, compared to the industry median CAGR of 0.00%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Alembic Ltd?
Promoters hold 70.88% of the Alembic Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Alembic Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 9.6% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Alembic Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 3.8%3.1%4.4%3.9%7.1%0.9%4.1%3.8%4.9%7%-
Value Creation
Index
-0.7-0.8-0.7-0.7-0.5-0.9-0.7-0.7-0.7-0.5-

Growth Parameters

Sales 13414712512473.973.578.2127157222240
Sales YoY Gr.-9.8%-14.9%-1.2%-40.3%-0.6%6.4%62.7%23.8%40.9%-
Adj EPS 8.85.568.312.813.28.57.710.41212.4
YoY Gr.--37.1%8%38.4%54.6%3.5%-35.4%-10.4%36.3%14.9%-
BVPS (₹) 30.134.140.747.155.289.597.280.985.191.189.6
Adj Net
Profit
235148160212328340219196268308317
Cash Flow from Ops. 9.751.623.621.56.5-2.2-17.838.922.786.4-
Debt/CF from Ops. 00000-0.1000.40.2-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 5.8%24.6%41.6%40.9%
Adj EPS 3.5%-1.3%11.9%14.9%
BVPS13.1%10.5%-2.2%7%
Share Price 9.7% -7% 8.4% -21.6%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
35.317.21618.52518.39.28.612.613.613.7
Op. Profit
Mgn %
4.54.68.914.64.314.217.831.736.142.237.7
Net Profit
Mgn %
18.620.330.632.4124.314.3106.767.958.563.7132.3
Debt to
Equity
00000000000
Working Cap
Days
404248217175258336488370359315164
Cash Conv.
Cycle
2651681318211018427722716611078

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales134147125124747478127157222
Operating Expenses + 12814011410671636487101128
Manufacturing Costs19137976891214
Material Costs76967967322223414969
Employee Cost 24232021212321242327
Other Costs 99910111212131718
Operating Profit 67111731014405794
Operating Profit Margin (%) 4.5%4.6%8.9%14.0%4.2%14.2%17.8%31.7%36.1%42.2%
Other Income + 29313730941189645575
Exceptional Items -3-600000-1100
Interest 0000000012
Depreciation 65433457811
Profit Before Tax 2527444593179887103156
Tax 1-124031261011
Profit After Tax 252742419314868193145
PAT Margin (%) 18.4%18.7%33.4%33.2%125.9%18.8%110.2%63.4%59.0%65.2%
Adjusted EPS (₹)8.85.46.18.312.813.48.77.410.512.1
Dividend Payout Ratio (%)1.70%3.70%3.30%2.40%4.70%1.50%20.80%29.60%22.90%19.80%

Valuation of Alembic - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 8039111,0861,2091,4182,2972,4972,0782,1862,339
Share Capital 53535351515151515151
Reserves 7508581,0321,1571,3672,2462,4452,0272,1342,287
Debt +00000000711
Long Term Debt00000000711
Short Term Debt0000000000
Minority Interest0000000000
Trade Payables16151625131819173128
Others Liabilities 566657334094116115111143
Total Liabilities 8759921,1591,2661,4712,4092,6322,2102,3352,520

Fixed Assets

Net Fixed Assets +146148132131131134134132131135
Gross Block372158144145145150151151152157
Accumulated Depreciation225111213151618192121
CWIP 00322219370010
Investments 5897329131,0011,1332,0472,2081,7541,7861,900
Inventories75513235355487899399
Trade Receivables2822251491415232030
Cash Equivalents 22125972224
Others Assets 3538246086116186211302351
Total Assets 8759921,1591,2661,4712,4092,6322,2102,3352,520

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 105224227-2-18392386
PBT 2527444593179887103156
Adjustment -17-21-29-21-862-79-53-42-53
Changes in Working Capital 2461221-19-2811-38-1
Tax Paid -1-0-4-5-2-2-9-71-16
Cash Flow From Investing Activity + -5-47-227257-3519726-27
Capex 1-14-9-23-22-47-34-25-56-51
Net Investments -28-59-3871-1011-27-2634-40
Others 2226252488180584865
Cash Flow From Financing Activity -5-5-3-92-6-15-6-46-48-58
Net Proceeds from Shares + 0000000000
Net Proceeds from Borrowing 0020000095
Interest Paid -0-0-0-0-0-0-0-0-1-2
Dividend Paid -5-5-5-6-6-15-5-46-56-61
Others -000-8500-0-000
Net Cash Flow -0-0-1157-52-5-001

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)3.713.214.183.587.080.753.63.524.366.39
ROCE (%)3.823.124.443.917.120.944.13.824.866.95
Asset Turnover Ratio0.180.160.120.10.050.040.030.050.070.09
PAT to CFO Conversion(x)0.41.930.570.540.08-0.14-0.210.480.250.59
Working Capital Days
Receivable Days103.5059.1067.3057.2055.5056.6067.7055.5050.1040.90
Inventory Days216.70149.70119.2099.80174.60222.70329.30251.70210157.90
Payable Days855972.50112.20217.20252.70299.20162.70180.40156.40

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Alembic Ltd FAQs

The current trading price of Alembic on 05-Jun-2026 09:51 is ₹87.15.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Jun-2026 the market cap of Alembic stood at ₹2,207.8 Cr

The latest P/E ratio of Alembic as of 04-Jun-2026 is 17.73.

The latest P/B ratio of Alembic as of 04-Jun-2026 is 3.26.

The 52-week high of Alembic is ₹125.7 and the 52-week low is ₹70.64.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Alembic is ₹232 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Alembic Ltd is a below average quality company.

The key valuation ratios of Alembic Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Alembic Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Alembic Ltd

Alembic is a Public Limited Company domiciled in India and is incorporated under the provisions of the Companies Act applicable in India. Its shares are listed on two recognised stock exchanges in India. The registered office of the Company is located at Alembic Road, Vadodara, Gujarat. The Company is dealing in Active Pharmaceutical Ingredient (API) Business and Real Estate Business.

Business area of the company

The company is primarily engaged in two businesses i.e.

API Manufacturing

  • Estolate
  • Biphenyl Valine Oxalate
  • Venlafaxine

Real Estate

  • Residential Projects
  • Commercial Project
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×